The Phase 2 TAHOE study, which is currently enrolling, evaluates the safety and efficacy of RVT-3101 in patients with moderate to severely active Crohn’s disease (CD) Roivant recently announced highly ...

In England, 37 people die each day from bowel cancer, but screening using faecal blood testing followed by a colonoscopy can reduce both the incidence of this cancer and the number of resulting deaths ...

Uptake of a cancer screening program is slowly improving with more than four in five participants returning to screen again ...

PARIS--(BUSINESS WIRE)--Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, announced today it received the second ...

Participation rates in the National Bowel Cancer Screening Program (NBCSP) have gradually improved over recent years, with over 4 in 5 participants ...